Epilepsy is a seizure disorder that is described by the International League Against Epilepsy as two unprovoked seizures that ...

For nearly one-third of the 3 million adults in the United States living with epilepsy, medications fail to control seizures.

With NIH support, biomedical engineer Sri Sarma develops neurotechnologies to improve understanding and treatment of epilepsy ...

A 21-year-old man, who had been suffering from epilepsy for 10 years, was finally cured of the neurological disease after an ...

Dawn Kenny undergoes Laser Interstitial Thermal Therapy surgery for epilepsy at The Alfred, led by neurosurgeon Dr Mathew ...

Epilepsy affects about 50 million people worldwide, making it one of the most common neurological disorders. In India, nearly ...

The drug, called tofacitinib, also restores short-term and working memory lost to epilepsy in the mice and reduces ...

This article is authored by Dr Amit Kumar Agarwal, senior consultant, neurosciences, neurology and stroke medicine, Amrita ...

A real-world study supports cenobamate as an effective option for patients with drug-resistant epilepsy even after multiple ...

Neurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...

If the drug proves viable for human patients, it would ... and how these are affected by a common form of epilepsy, have been identified by a team of neurologists and neurosurgeons at ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.